Affiliation:
1. Nephrology Division, New York Grossman School of Medicine, NYU Langone Health, New York, New York
2. Internal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York
3. NYU Health Sciences Library, NYU Grossman School of Medicine, NYU Langone Health, New York, New York
Abstract
Key Points
Among the studies included, women were first authors of minority of the publications, and this trend persisted over the 20 years.Crude citation rates were lower in papers with female first authors; the gender of the author was not independently associated with citation metrics.
Background
Historically, women's scientific contributions have been under-recognized. We investigated whether the number of citations, a key metric used for academic promotions and scientific productivity, differs in nephrology high-impact publications on the basis of author's gender.
Methods
We identified randomized clinical trials from 2000 to 2021 in ten high-impact journals. We assessed author gender, citations, h-index, m-index, years of active publishing, education, and grant funding. The main predictor of interest was the gender of the first author. The main outcome was the standardized citation count for analysis of the selected publications. In addition, we evaluated standardized author citation counts using the author, rather than the article.
Results
Among the selected publications, women were first authors of 65 (17.1%) and men of 315 (82.9%) articles. In crude analyses, publications with male first authors had a significantly higher median number of standardized citations (14 versus 10, P = 0.01). Adjusted analyses revealed m-index (β=29.48, P ≤ 0.01) and journal impact factor (β=0.78, P < 0.001) were significantly associated with the standardized citation index. By contrast, neither the gender of the first author (β
male gender=1.42, P = 0.71) nor of the last author (β
male gender=8.89, P = 0.38) were significantly associated with the standardized citations. Similarly, in adjusted analyses on the basis of author profiles, male authorship was not significantly associated with the standardized author citation number (β
male gender=−7.79, P = 0.08).
Conclusions
Our study highlights marked disparities in the overall number of women publishing high-impact nephrology trials and the number of articles with female scientists as first authors of high-impact trials in the nephrology literature. Although crude citation rates were lower in articles with female first authors, the gender of the first author was not independently associated with citation metrics. Addressing gender disparities in academic recognition requires nuanced approaches extending beyond authorship and a broader focus on complex factors that influence academic recognition and scientific contributions.
Funder
ASN Foundation for Kidney Research
Publisher
Ovid Technologies (Wolters Kluwer Health)